Jubilant Ingrevia Limited Commissions New Facility For Diketenes and Derivatives

18 Feb 2022
Noida, UP, India, February16, 2022: Jubilant Ingrevia Limited,a global integrated Life Science products and Innovative Solutions provider withover 42 years of experience offeringover 165 products& innovative solutions using more than 35 key chemistry and technology platforms across its three portfolio of businessesviz Acetyls, Pyridines and Vitamins& Premixes, today announced the commissioning of its new Diketene derivatives facility at its manufacturing site in North India atGajraula, Uttar Pradesh.

Jubilant Ingrevia Limitedfor many years has niche expertise in using Ketene chemistry technology. Using the Ketene chemistry capability,the Company has developed a range of Diketene Derivatives.The newly commissioned facilitymarks the entry of Jubilant Ingrevia Limitedinto the fast growing Diketene business portfolio. This reiteratesJubilant Ingrevia Limited’scommitment towards growth through its integrated business model, by providing value added products & innovative solutions to its customers.

The commissioned facility has about 7,000 TPA capacity to produce various Esters (Mono Methyl Acetoacetamide, Methyl Acetoacetate, Ethyl Acetoacetate and Ter-Butyl Acetoacetate). The Company’s long-standing association with leading customers in Pharmaceuticals, Agrochemicals and other industries and its advance efforts to get product approval from customers, will help in utilizing a major portion of the capacity of this new facility in the coming months. Jubilant Ingrevia Limitedundertakes to commission future phases of Diketene Derivativesas per plan.
On this occasion, Mr. Rajesh Srivastava, Chief Executive Officer and Managing Director, Jubilant Ingrevia Limited said,

“It gives me immense pleasure to showcase yet another instance where Jubilant Ingrevia Limited has developed a strong chemistry platform proposition using inhouse R&D and technology transfer backed with high operating excellence and clear strategic direction. The commercial launch of the Diketene facility marks the next stage in the growth of the Company, positioning us closer to our client’s requirements of innovative products and solutions using novel and niche chemistry platform."


News Articles More

Contact Now
Have a question or feedback, let us know!

Please enter the string as shown above: